Published in J Clin Oncol on June 01, 1992
Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol (2009) 2.33
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. Br J Cancer (2006) 1.16
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors. Clin Cancer Res (2012) 1.06
Subclinical ventricular dysfunction detected by speckle-tracking two years after use of anthracycline. Arq Bras Cardiol (2015) 1.06
Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group. J Clin Pharmacol (2008) 0.94
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol (2012) 0.89
Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS One (2015) 0.83
Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention. PLoS One (2015) 0.78
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer. Br J Cancer (2005) 0.76
Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis. Rheumatol Int (2007) 0.76
Wegener's granulomatosis presenting as dilated cardiomyopathy. West J Med (1996) 0.75
Effect of bone marrow transplantation on diastolic function indices. Int J Clin Exp Med (2013) 0.75
Bone marrow transplantation may augment cardiac systolic function in patients with a reduced left ventricular ejection fraction. J Cardiovasc Dis Res (2012) 0.75
Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase. PLoS One (2012) 0.75
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner. Cell Death Dis (2017) 0.75
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma. Eur J Cancer (2016) 0.75
Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. Br J Haematol (2016) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med (1994) 5.03
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Bedford glaucoma survey. Br Med J (1968) 3.77
Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol (1996) 3.59
Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med (1997) 3.48
Postoperative mediastinitis: classification and management. Ann Thorac Surg (1996) 3.42
Efficient transfer of highly resolved small DNA fragments from polyacrylamide gels to DBM paper. Gene (1980) 3.30
Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med (1993) 3.25
TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature (2002) 3.23
Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med (1975) 2.71
Estimated prevalence of anabolic steroid use among male high school seniors. JAMA (1988) 2.71
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
The nature and control of infections in patients with acute leukemia. Cancer Res (1965) 2.55
Improved survival for patients with acute myelogenous leukemia. J Clin Oncol (1995) 2.30
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Pleomorphic adenoma of the lacrimal gland. Br J Ophthalmol (1992) 2.27
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med (1988) 2.23
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol (2005) 2.23
Meiotic models to explain classical linkage, pseudolinkage, and chromosome pairing in tetraploid derivative salmonid genomes. Isozymes Curr Top Biol Med Res (1983) 2.22
Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion (1997) 2.17
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol (1992) 2.10
The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol (1983) 2.08
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med (1974) 2.02
Pseudolinkage of the duplicate loci for supernatant aspartate aminotransferase in brook trout, Salvelinus fontinalis. J Hered (1980) 1.97
Assessment of established cases of chronic simple glaucoma. Br J Ophthalmol (1970) 1.94
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science (1990) 1.93
Cytogenetic analysis of pseudolinkage of ldh Loci in the teleost genus salvelinus. Genetics (1973) 1.92
Venous malformations in the orbit. Br J Ophthalmol (1971) 1.90
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res (1978) 1.88
Late relapse of testicular cancer. J Clin Oncol (1995) 1.87
Clinical trials with adriamycin. Cancer (1971) 1.86
Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol (1996) 1.85
Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol (1997) 1.81
Genome size and complexity in Azotobacter chroococcum. J Gen Microbiol (1984) 1.79
Spilled gallstones after laparoscopic cholecystectomy. A relevant problem? A retrospective analysis of 10,174 laparoscopic cholecystectomies. Surg Endosc (1998) 1.77
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
A lesson from Canada: Ontario's health insurance. N Engl J Med (1978) 1.76
Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (1974) 1.74
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol (1998) 1.72
Controlled multicenter trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice herniorrhaphy. Early results. Surg Endosc (1996) 1.71
Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. Acta Cytol (1985) 1.70
The Polycomb-group gene, extra sex combs, encodes a nuclear member of the WD-40 repeat family. EMBO J (1995) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg (1994) 1.65
Complications of laparoscopic cholecystectomy in Switzerland. A prospective 3-year study of 10,174 patients. Swiss Association of Laparoscopic and Thoracoscopic Surgery. Surg Endosc (1998) 1.65
Gastrointestinal sarcomas. Semin Oncol (1988) 1.62
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun (2001) 1.60
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Case report of granular cell myoblastoma arising within the medial rectus muscle. Br J Ophthalmol (1983) 1.58
Isometric, isotonic, and isokinetic torque variations in four muscle groups through a range of joint motion. Phys Ther (1983) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol (1989) 1.55
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Societal alternatives to anabolic steroid use. Clin J Sport Med (2000) 1.50
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Studies of patients in a laminar air flow unit. Cancer (1969) 1.49
Combination cancer therapy: Presidential address. Cancer Res (1972) 1.47
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Intensive combination chemotherapy and X-irradiation in Hodgkin's disease. Cancer Res (1967) 1.44
Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet (1988) 1.43
Primary optic nerve meningiomas: clinical presentation and management. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1977) 1.42
Selection bias in clinical trials. J Clin Oncol (1985) 1.42
Prevalence of acne keloidalis nuchae in football players. J Am Acad Dermatol (1997) 1.41
Field evaluations of insect growth regulators, insecticides, and a bacterial agent for stable fly control in feedlot breeding areas. J Econ Entomol (1976) 1.40
Inflammatory orbital pseudotumor. A clinicopathologic study. Arch Ophthalmol (1978) 1.40
Coronary artery bypass surgery and minor aortic stenosis--to replace or not to replace? J Heart Valve Dis (1993) 1.40
Defining new standards for adjuvant therapy of testis cancer. J Clin Oncol (1995) 1.39
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
Adenocarcinoma of lacrimal gland. Ophthalmology (1994) 1.39
Complex regulation of early paired expression: initial activation by gap genes and pattern modulation by pair-rule genes. Development (1993) 1.39
Preoperative Nyhus classification of inguinal hernias and type-related individual hernia repair. A case for diagnostic laparoscopy. Surg Laparosc Endosc (1997) 1.39
Dosimetry of swallowed non absorbed 99mTc radiopharmaceuticals in pediatric patients. Eur J Nucl Med (1990) 1.39
[Early results of the initial 100 laparoscopic hernia operations under peridural anesthesia]. Schweiz Med Wochenschr (1995) 1.39
Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. Cancer Res (1976) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Effect of breathing on the detection of in vivo simulated pulmonary nodules by spiral CT. Clin Radiol (1998) 1.38
Orbital xanthogranuloma in adults. Br J Ophthalmol (1991) 1.37
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. Cancer (1971) 1.37
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. Clin Pharmacol Ther (1972) 1.35
Clinical presentation and management of lacrimal gland tumours. Br J Ophthalmol (1979) 1.35
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis (1994) 1.34
Orbital hemorrhage. Am J Ophthalmol (1979) 1.34
Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol (2000) 1.33
Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res (1969) 1.33